comprehensive -WSS

comprehensive

author：fashion 2025-09-27 22:50:07 - browse：3975

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Will the FTC rein in IQVIA's health data empire?

WSS

Humana cuts profit projections as Medicare Advantage costs soar

Why doctors need education on FDA device approval process

Rise in cancer among younger people worries and puzzles doctors

Device maker Teleflex to acquire urology company for $600M

Truvian presents data for its desktop blood

New Alzheimer's drugs heat up race for early detection blood tests

focus

comprehensive

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

Search called off for baby washed away in Pennsylvania flash flood

Jerome Adams on the need for new antivirals for Covid

Research misconduct: Proposed new rules face resistance

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

EU regulator recommends expanding Mounjaro approval to obesity

How one medical school became remarkably diverse

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Supreme Court strikes down use of affirmative action

What it's like to live with paralysis for one psychologist

leisure time

Device maker Teleflex to acquire urology company for $600M

New lawsuit accuses health insurer Cigna of denying claims in bulk

eGenesis tests gene

Independent physicians launch a new lobbying group

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Biden warns of ‘dark winter’ during final presidental debate

focus

hotspot

focus

hotspot